Congruent with published reports 3941 , further analysis of the single-cell data (GSE245657) revealed pathways involved in T cell activation, differentiation, chemotaxis, and interferon-mediated signaling were uniformly suppressed in activated GLP1R + TILs relative to activated GLP1R -TILs, as determined by GSEA of gene ontology biological process (GOBP) ( Supplementary Figure 4D )

Certain features warrant prompt medical evaluation: Severe muscle pain or weakness , particularly if accompanied by dark urine, which may indicate rhabdomyolysis (a rare but serious condition involving muscle breakdown) Joint swelling, redness, or warmth , which could suggest inflammatory arthritis or infection (septic arthritis) Pain that significantly impairs daily activities or does not respond to simple analgesia Systemic symptoms such as fever, unexplained weight loss (beyond expected therapeutic effect), or night sweats New or worsening pain following dose escalation, which may require dose adjustment or further investigation Sudden, severe pain in the right upper abdomen , possibly with fever or jaundice, which could indicate gallbladder disease (a recognised risk with GLP-1 receptor agonists) [1] [5] Patients should also seek advice if they experience other concerning adverse effects of Ozempic, including: Persistent nausea or vomiting leading to dehydration or reduced fluid intake Symptoms of hypoglycaemia (tremor, sweating, confusion), particularly if taking Ozempic with insulin or sulphonylureas Severe abdominal pain, which may indicate pancreatitis (a known but uncommon risk with GLP-1 receptor agonists) [1] [5] Visual changes or signs of diabetic retinopathy progression For urgent concerns outside of GP hours, patients should contact NHS 111

It is a prescription medication that is only available with a prescription from a Healthcare provider
If you have an existing thyroid condition or concerns about your thyroid health while using Ozempic, talk with your doctor
Hepatitis B is an infectious disease caused by HBV, and if not treated promptly, chronic HBV (CHB) infection is highly likely to progress to advanced liver diseases such as cirrhosis and hepatocellular carcinoma (HCC)